ASE Market Wrap-Up
16 May 2013
Banking and mining stocks weigh on the market
ASE General Index
Arms Index (TRIN)*
Jordanian shares saw a pullback on Wednesday as investors pocketed gains in banking and
mining stocks. Sector indices end the day mixed with weakness in Industrials (-0.40%),
Services (-0.33%), and Banking (-0.21%) dragging the index lower. Heavyweights Arab
Bank (ARBK) & Jordan Phosphate Mines (JOPH) fell 0.7% and 4.1% respectively for the day. The general index ended the session at 2017.7; down by 0.26%
Jordanian and Arab investors were net buyers while foreign investors were net sellers>
Retail investors were net buyers while Institutional investors were net sellers.
Citi Bank-Amman recorded a net profit of JD5.06million during FY2012 compared to JD1.30 in the previous year; up by 288%.
Amman-based Hikma Pharmaceuticals Plc. raised its full year revenue forecast as its
generic antibiotic doxycycline generated revenues ahead of its expectations. Hikma expects
group revenues to rise around 13% in 2013.
World Economic Forum (WEF) on Middle East and North Africa 2013 will be held at the
Dead Sea Jordan between the 24th and 26th of May 2013 under the theme "Advancing
Top Value Traded
Conditions for Growth and Resilience". The forum will convene over 900 of the foremost leaders from the Gulf Cooperation Council countries, the Levant, North Africa and
internationally. Representing government, industry, media, civil society and youth, these
stakeholders will come together to advance understanding, dialogue and action on the most immediate and urgent priorities as well as long-term imperatives.
According to Al-Arab Al-Yawm newspaper, a government report said that the decision to liberalize fuel prices, taken in November of last year, contributed to 50% of the increase in
Trading by Investor Type
consumer prices during the first quarter of 2013.
Jordan’s clothing and apparel exports increased by 5% YOY during the first quarter of 2013
to reach JD286 million, up from JD272 million during the same period last year.
ASE Market Wrap-Up
Thu 30 May: The Jordan Pharmaceutical Manufacturing (JPHM) AGM Mon 10 Jun: The Jordan Magnesia Company (JMAG) AGM
ASE Daily Top 30
Net Income (JD Mil)
Report P/E TTM
P/BV Div. Yield
6M 2012 FY 2012 Q1 2013
ASE Top 30 totals
A: Ratios are based on FY 2011 results Q4: Ratios are based on FY 2012 results NEG: P/E ratio is negative
A short-term technical analysis breadth indicator calculated as (Advancing Issues / Declining Issues) / (Advancing Volume / Declining Volume).
A ratio of 1 means the market is in balance; above 1 indicates that more volume is moving into declining stocks; and below 1 indicates that more volume is moving into advancing stocks.
The information and opinions contained in this document have been compiled in good faith from sources believed to be reliable. Capital
Investments makes no warranty as to the accuracy and completeness of the information contained herein. All opinions and estimates
included in this report constitute and reflect our independent judgment as of the date published on the report and are subject to
change without notice. Capital Investments accepts no liability whatsoever for any loss of any kind arising out of the use of all or any
part of this report. Capital Investments and its related companies may have performed or seek to perform any financial or advisory
services for the company mentioned in this report. Capital Investments, its funds, or its employees may from time to time take positions or effect transactions in the securities issued by the company mentioned in this report .This document may not be reproduced in any form without the expressed written permission of Capital Investments.
ESTATUTOS SOCIALES DE SOCOTHERM AMERICAS S.A. ARTÍCULO I. DENOMINACIÓN Esta Sociedad, cuyos estatutos originales fueron aprobados con la denominación de “Soco-Ril S.A.” por el Registro Público de Comercio de la ciudad del Neuquén, provincia del mismo nombre, el 17 de noviembre de 1989, bajo el N° 233, en los Folios 1027/1033, Tomo VII, continuará funcionando con el nombr
Pharmacy Department Policies and Procedures MEDICATION MONITORING: INTRAVENOUS TO ORAL THERAPEUTIC INTERCHANGE I. BACKGROUND The oral route of administration may be ideal so long as the medication achieves the desired concentrations in blood and/or the targeted site(s) of action. Patients often start on parenteral therapy, but as their condition improves, they are often candidat